Inhibitory effect of lidocaine on colon spasm: A multicenter double-blind, randomized controlled trial

Inhibitory effect of lidocaine on colon spasm: A multicenter double-blind, randomized controlled trial - LIDO Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024733

Enrollment

128

Registered

2016-11-08

Start date

2016-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients receiving colonoscopy for endoscopic resection of colorectal lesions

Interventions

dispersion of 2% lidocaine solution 20mL dispersion of saline 20mL

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with colorectal lesions scheduled for endoscopic resection

Exclusion criteria

Exclusion criteria: hypersensitivity to lidocaine inflammatory bowel disease, i.e., ulcerative colitis, crohn disease intestinal dysfunction, e.g., pseudo-obstruction females with pregnancy or suspicion history of colorectal resection

Design outcomes

Primary

Measure	Time frame
inhibitory effect on intestinal spasm	—

Secondary

Measure	Time frame
rebound spasm, symptom associated with the dispersion, adverse event, blood level of lidocaine	—

Countries

Japan

Contacts

Public ContactJinko Kobayashi

Aizu Medical Center, Fukushima Medical University Department of Coloproctology

togashik@fmu.ac.jp0242-75-2100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026